Y. Jeske

755 total citations
20 papers, 576 citations indexed

About

Y. Jeske is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Y. Jeske has authored 20 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Y. Jeske's work include Hormonal Regulation and Hypertension (8 papers), Sexual Differentiation and Disorders (5 papers) and Ovarian cancer diagnosis and treatment (3 papers). Y. Jeske is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), Sexual Differentiation and Disorders (5 papers) and Ovarian cancer diagnosis and treatment (3 papers). Y. Jeske collaborates with scholars based in Australia, United States and Italy. Y. Jeske's co-authors include Peter Koopman, Josephine Bowles, Andy Greenfield, Paul R. Martin, Matthew Hobbs, John S. Mattick, Richard D. Gordon, Michael Stowasser, David L. Duffy and Catherine S. Choong and has published in prestigious journals such as Nature Genetics, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.

In The Last Decade

Y. Jeske

20 papers receiving 567 citations

Peers

Y. Jeske

GENET

EDM

SURGE

Kristal Weaver United States

Christina Bracken United States

Jin-Yi Jiang Canada

Begoña Ezquieta Spain

Karen Carpenter United States

Cecilia Petersen Sweden

Feixue Li China

Giorgia Rizzo Italy

Jinyi Tong China

Kristal Weaver United States

Y. Jeske

225 ×0.6

55 ×0.2

GENET

22 ×0.1

EDM

23 ×0.2

SURGE

38 ×0.4

Citations per year, relative to Y. Jeske Y. Jeske (= 1×) peers Kristal Weaver

Countries citing papers authored by Y. Jeske

Since Specialization

Citations

This map shows the geographic impact of Y. Jeske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Jeske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Jeske more than expected).

Fields of papers citing papers by Y. Jeske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Jeske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Jeske. The network helps show where Y. Jeske may publish in the future.

Co-authorship network of co-authors of Y. Jeske

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Jeske. A scholar is included among the top collaborators of Y. Jeske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Jeske. Y. Jeske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeske, Y., Shamshad Ali, Sara A. Byron, et al.. (2017). FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 145(2). 366–373. 41 indexed citations

Powell, Matthew A., Michael W. Sill, Paul J. Goodfellow, et al.. (2014). A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. 135(1). 38–43. 1 indexed citations

Jeske, Y., Mark Harris, Francis Bowling, et al.. (2009). 21-Hydroxylase Genotyping in Australasian Patients with Congenital Adrenal Hyperplasia. Journal of Pediatric Endocrinology and Metabolism. 22(2). 127–41. 9 indexed citations

Sukor, Norlela, Paolo Mulatero, Richard D. Gordon, et al.. (2008). Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. Journal of Hypertension. 26(8). 1577–1582. 57 indexed citations

Jeske, Y., et al.. (2007). Genetic basis of familial hyperaldosteronism type II: Further evidence of linkage at chromosome 7p22. Hypertension. 49(6). 1477–1477. 1 indexed citations

Jeske, Y., David Cowley, Christine Oley, et al.. (2007). Androgen Receptor Genotyping in a Large Australasian Cohort with Androgen Insensitivity Syndrom? Identification of Four Novel Mutations. Journal of Pediatric Endocrinology and Metabolism. 20(8). 893–908. 10 indexed citations

Stowasser, Michael, Francesco Fallo, Y. Jeske, et al.. (2007). Genetic Forms of Primary Aldosteronism. High Blood Pressure & Cardiovascular Prevention. 14(2). 75–81. 4 indexed citations

Greer, Ristan M., Y. Jeske, David Brown, et al.. (2007). Genotype-Phenotype Associations in Patients with Severe Hyperinsulinism of Infancy. Pediatric and Developmental Pathology. 10(1). 25–34. 14 indexed citations

Stowasser, M., et al.. (2005). Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion. Clinical and Experimental Pharmacology and Physiology. 32(7). 1 indexed citations

10.

Stowasser, M., et al.. (2005). Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity. Clinical and Experimental Pharmacology and Physiology. 32(7). 1 indexed citations

11.

Duffy, David L., Richard D. Gordon, Y. Jeske, et al.. (2005). Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. Journal of Hypertension. 23(8). 1477–1484. 70 indexed citations

12.

Jeske, Y., et al.. (2005). No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample. American Journal of Hypertension. 18(5). A6–A6. 1 indexed citations

13.

Elphinstone, Martin S., et al.. (2004). Genomic structure of the human gene for protein kinase A regulatory subunit R1‐beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clinical Endocrinology. 61(6). 716–723. 14 indexed citations

14.

Jeske, Y., Andrew Cotterill, David Cowley, et al.. (2003). Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clinical Endocrinology. 58(6). 785–794. 45 indexed citations

15.

Choong, Catherine S., Peter J. Fuller, Simon Chu, et al.. (2002). Sertoli-Leydig Cell Tumor of the Ovary, a Rare Cause of Precocious Puberty in a 12-Month-Old Infant. The Journal of Clinical Endocrinology & Metabolism. 87(1). 49–56. 14 indexed citations

16.

Wheatley, Susan C., et al.. (1996). Aetiology of the Skeletal Dysmorphology Syndrome Campomelic Dysplasia: Expression of the Sox9 Gene during Chondrogenesis in Mouse Embryosa. Annals of the New York Academy of Sciences. 785(1). 350–352. 8 indexed citations

17.

Jeske, Y., Yuji Mishina, Donna Cohén, Richard R. Behringer, & Peter Koopman. (1996). Analysis of the role ofAmh andFra1 in theSry regulatory pathway. Molecular Reproduction and Development. 44(2). 153–158. 26 indexed citations

18.

Jeske, Y., Yuji Mishina, Donna Cohén, Richard R. Behringer, & Peter Koopman. (1996). Analysis of the role of Amh and Fra1 in the Sry regulatory pathway. Molecular Reproduction and Development. 44(2). 153–158. 1 indexed citations

19.

Jeske, Y., Josephine Bowles, Andy Greenfield, & Peter Koopman. (1995). Expression of a linear Sry transcript in the mouse genital ridge. Nature Genetics. 10(4). 480–482. 146 indexed citations

20.

Martin, Paul R., et al.. (1993). Characterization of pilQ, a new gene required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa. Molecular Microbiology. 9(4). 857–868. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact